PubRank

Hoosen Coovadia

Author PubWeight™ 90.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004 16.28
2 CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2006 10.34
3 Is Option B+ the best choice? Lancet 2013 6.17
4 Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Med 2010 5.54
5 A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003 4.49
6 Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet 2009 3.35
7 Sub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions? PLoS Med 2010 2.77
8 Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 2008 2.72
9 Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 2011 2.41
10 HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J Virol 2008 2.14
11 Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 2005 2.11
12 Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 2008 2.06
13 Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010 1.97
14 Role of traditional birth attendants in preventing perinatal transmission of HIV. BMJ 2002 1.72
15 Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J Infect Dis 2005 1.58
16 Excellent can be the enemy of good: the case of diarrhoea management. Lancet 2013 1.52
17 Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS 2005 1.41
18 Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull 2013 1.38
19 Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS 2010 1.22
20 Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol 2007 1.21
21 Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J Virol 2009 1.20
22 Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis 2005 1.20
23 The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2007 1.19
24 Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr 2004 1.16
25 Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS One 2010 1.12
26 Women's morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS 2010 1.03
27 Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress. J Infect 2013 0.99
28 Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings. Future Virol 2011 0.98
29 Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003 0.95
30 Is Option B+ the best choice? Authors' reply. Lancet 2013 0.94
31 Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr 2014 0.93
32 Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS. N Engl J Med 2004 0.91
33 HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr 2013 0.90
34 Rare HLA drive additional HIV evolution compared to more frequent alleles. AIDS Res Hum Retroviruses 2009 0.88
35 Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa. AIDS Res Hum Retroviruses 2011 0.87
36 Short communication: CD4 counts of HIV-infected pregnant women and their infected children--implications for PMTCT and treatment programmes. Trop Med Int Health 2007 0.87
37 Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. AIDS 2012 0.83
38 Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet 2002 0.79
39 Adolescents and HIV in sub-Saharan Africa: a timely issue and missed opportunity. Clin Infect Dis 2010 0.78
40 Integrating tuberculosis services into a PMTCT HIV programme in South Africa. Int J Tuberc Lung Dis 2013 0.77
41 The versatile lymphocyte count. Lancet 2004 0.75
42 Top stories of 2004. Perinatal transmission interventions: the benefits come with resistance. AIDS Clin Care 2005 0.75
43 Hoosen Coovadia: an icon of South African health. Interview by Clare Kapp. Lancet 2009 0.75
44 Roundtable. Revisiting the role of single-dose nevirapine for preventing perinatal HIV transmission. AIDS Clin Care 2005 0.75